Dammer R, Wurm E M, Niederdellmann H, Fleischmann H, Knüchel R
Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie, Universität Regensburg.
Mund Kiefer Gesichtschir. 1997 Mar;1(2):95-103. doi: 10.1007/BF03043522.
In a prospective pilot study we investigated the percentage of immunocompetent cells in the peripheral blood in 146 patients (lymphocytes, leucocytes, monocytes, T cells, B cells, NK cells, T-helper cells, T-suppressor cells, ratio T-helper/T-suppressor cells, activated T cells HLA-DR) by flow cytometry. The immunologic parameters were derived from patients with oral and oropharyngeal squamous cell carcinomas, precancerous lesions and benign tumours and from a group of heavy smokers and alcoholics. Carcinoma patients (n = 46) were compared with risk groups and a reference group consisting of patients with inflammatory disease. Within the collective of carcinoma patients we measured the immune status before and after chemo-, radio- and operative therapy. We also analysed the immune parameters in relation to clinical and histomorphological parameters (TNM status, grading). The univariate analysis of monocytes showed significant relationships between on the one hand carcinoma patients and on the other alcoholics and those with benign tumours and precancerous lesions. In precancerous lesions NK cells were significantly increased compared with alcoholics and the reference group. A significant decrease in B cells in carcinoma patients may show incipient insufficiency of the humoral immunity. The immune parameters showed a different reaction depending on therapy. After irradiation we found a significant increase of T-suppressor cytotoxic cells and decreases in B and T-helper cells. Chemotherapy showed an increase in T and T-helper cells and a decrease in B cells. Surgical therapy alone yielded an increase in B cells. The comparison of all pre- and posttherapeutic parameters showed significant changes only in activated T cells HLA-DR. We found no correlation between prognostic clinico-pathological factors and immune parameters. No changes were found in a multivariate analysis.
在一项前瞻性试点研究中,我们通过流式细胞术调查了146例患者外周血中免疫活性细胞的百分比(淋巴细胞、白细胞、单核细胞、T细胞、B细胞、NK细胞、辅助性T细胞、抑制性T细胞、辅助性T细胞/抑制性T细胞比值、活化T细胞HLA-DR)。免疫参数来源于口腔和口咽鳞状细胞癌、癌前病变和良性肿瘤患者以及一组重度吸烟者和酗酒者。将癌症患者(n = 46)与风险组以及由炎症性疾病患者组成的参照组进行比较。在癌症患者群体中,我们测量了化疗、放疗和手术治疗前后的免疫状态。我们还分析了免疫参数与临床和组织形态学参数(TNM分期、分级)之间的关系。单核细胞的单因素分析表明,一方面癌症患者与另一方面酗酒者以及患有良性肿瘤和癌前病变的患者之间存在显著关系。与酗酒者和参照组相比,癌前病变中的NK细胞显著增加。癌症患者中B细胞的显著减少可能表明体液免疫开始不足。免疫参数根据治疗显示出不同的反应。放疗后,我们发现抑制性细胞毒性T细胞显著增加,B细胞和辅助性T细胞减少。化疗显示T细胞和辅助性T细胞增加,B细胞减少。单纯手术治疗使B细胞增加。所有治疗前和治疗后参数的比较仅显示活化T细胞HLA-DR有显著变化。我们发现预后临床病理因素与免疫参数之间无相关性。多因素分析未发现变化。